Most likely, none of us will ever forget 2020. A virus kept the world in suspense. The pandemic has presented us all with many challenges. In many enterprises, it accelerated the implementation of digitalization. This has also been felt by d.velop Life Sciences — with positive effects for us.
“With 18 new customers in 2020 we achived by far the largest increase in direct-to-consumer business since the company was founded. This was also reflected in an extraordinarily strong sales growth of almost 40% compared to the previous year”, says Thilo Gukelberger, managing partner of d.velop Life Sciences GmbH.
“We have responded and have already reinforced our team with five new hires in 2021 to now over 50 employees. This means that we can continue to meet the growing demand for our specialist solutions,” Gukelberger states.